Evidence map›Paper›PMID 38026328›Full record

ArticleFrontiers in public health2023

The impact of Chinese COVID-19 pandemic on the incidence of peripheral facial nerve paralysis after optimizing policies.

Erhui Yu, Fanyuan Jin, Wenhui Zhou, Junkang Chen, Huafeng Cai, Jinhua Hu, Lihua Xuan

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Erhui YuThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Fanyuan JinThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Wenhui ZhouThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Junkang ChenThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Huafeng CaiThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Jinhua HuThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Lihua XuanDepartment of Acupuncture and Moxibustion, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.
Zhejiang Chinese Medical University · CNZhejiang Provincial Hospital of TCM · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the impact of the COVID-19 pandemic on the occurrence of Peripheral Facial Nerve Paralysis (PFNP) in Chinese patients, identify contributing factors, and explore the relationship between COVID-19 and PFNP. Methods: We conducted a retrospective study covering the years 2020 to 2023, categorizing patients into three groups based on their visit dates: Group 1 (December 8, 2020 to February 28, 2021), Group 2 (December 8, 2021 to February 28, 2022), and Group 3 (December 8, 2022 to February 28, 2023). We collected and compared data on disease onset and patient characteristics among these groups. Results: In Group 3, following the widespread COVID-19 outbreak, there was a significant increase of 22.4 and 12.1% in PFNP cases compared to the same periods in the preceding 2 years ( Conclusion: The incidence of PFNP increased in China after the COVID-19 pandemic, particularly in patients with Hunter syndrome, indicating that COVID-19 infection can trigger and worsen PFNP.

Indexed as

COVID-19Facial ParalysisMucopolysaccharidosis IIAdultEast Asian PeopleFacial NerveHumansIncidenceMiddle AgedPandemicsPolicyRetrospective StudiesChinaCOVID-19H-B scoreHunter syndromeperipheral facial nerve paralysis

Identifiers

PMID38026328
PMCPMC10654624
OpenAlexW4388298279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.